Department of Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.
Colorectal Dis. 2010 Apr;12(4):304-9. doi: 10.1111/j.1463-1318.2009.01788.x. Epub 2009 Feb 4.
The current guidelines identify the retrieval of at least 12 lymph nodes as crucial for accurate staging of colorectal cancer. We set out to review our figures from a single centre to see whether this standard has been met, and to examine for factors which may influence the number of lymph nodes retrieved. The influence of a low lymph node harvest on survival in patients with Dukes' A and B cancers was specifically investigated.
Data were collected from all patients with colorectal cancer undergoing resectional surgery from our prospectively compiled database between June 1998 and May 2007. A multivariate analysis was performed to identify factors resulting in low lymph node yields in those patients undergoing formal resection. Survival analyses were performed in patients with Dukes' A and B cancers to assess whether a low lymph node yield negatively impacted on survival.
A total of 2449 patients underwent formal resection and were included in the analysis. The median lymph node retrieval was 13 nodes (range 0-136). On multivariate analysis, preoperative chemo-radiotherapy, operation type, specimen length and patient age all independently influenced lymph node retrieval. Patient gender, ethnicity, operative mode, operative team and consultant presence had no influence. Survival in patients with Dukes' A and B cancers was significantly reduced if <12 nodes were sampled.
As a unit, we are achieving the national standard for lymph node harvest. This standard was maintained whether the surgeon performing the surgery was a consultant or a trainee, and also when the surgery was performed in the emergency setting. These data support the concept of 12 nodes being required for accurate staging.
目前的指南确定至少检索 12 个淋巴结对于结直肠癌的准确分期至关重要。我们旨在回顾我们单中心的数据,以了解是否达到了这一标准,并检查可能影响淋巴结检出数量的因素。特别调查了低淋巴结检出量对 Dukes' A 和 B 期癌症患者生存的影响。
从 1998 年 6 月至 2007 年 5 月期间,我们从前瞻性收集的数据库中收集了所有接受结直肠癌切除术的患者数据。对多变量分析进行了操作,以确定在接受正式切除术的患者中导致低淋巴结产量的因素。对 Dukes' A 和 B 期癌症患者进行生存分析,以评估低淋巴结产量是否对生存产生负面影响。
共有 2449 例患者接受了正式切除术并纳入分析。中位数淋巴结检出量为 13 个(范围 0-136)。多变量分析显示,术前化疗-放疗、手术类型、标本长度和患者年龄均独立影响淋巴结检出量。患者性别、种族、手术方式、手术团队和顾问的存在没有影响。如果取样<12 个淋巴结,Dukes' A 和 B 期癌症患者的生存显著降低。
作为一个单位,我们达到了国家淋巴结检出量的标准。无论是顾问还是受训者进行手术,以及在急诊环境下进行手术,这一标准都得到了维持。这些数据支持需要 12 个淋巴结进行准确分期的概念。